Large pericardial effusion as a complication in adults undergoing SCT

Maxim Norkin(Centre Hospitalier Universitaire Vaudois), Joseph P. Uberti(Sheba Medical Center), Voravit Ratanatharathorn(University of Michigan–Ann Arbor), Zaid Al‐Kadhimi(University of Nebraska Medical Center), Lois Ayash(Wayne State University), Muneer H. Abidi(Spectrum Health), Lawrence G. Lum(University of Virginia)

Bone Marrow Transplantation

November 29, 2010

10.1038/bmt.2010.297

Cited by 46

Related Papers

Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia

|New England Journal of Medicine|1986|1.5k

Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial

|The Lancet|2015|740

Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis

|Blood|2016|554

Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research

|Biology of Blood and Marrow Transplantation|2014|442

Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial

|Journal of Clinical Oncology|2013|439